Clinical Trial Update: Acitretin in Preventing Skin Cancers in Patients With Previously Treated Skin Cancers Who Have Undergone Organ Transplantation [NA]

View source ↗

Summary

A completed clinical trial evaluating acitretin to prevent new skin cancers in organ transplant recipients with a prior history of skin cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-melanoma Skin Cancer

Drugs mentioned

• Acitretin (Acitretin)

Snippet

Sponsor: Alliance for Clinical Trials in Oncology | Conditions: Non-melanomatous Skin Cancer | NA | Status: COMPLETED